Industry: Medical Devices & Consumables
Published Date: 2026-01-05
Pages: 123 Pages
Report ld: 5511103
Request Sample
Customized Report
Assisted Reproductive Apparatus Market Size(US$)

CAGR 2026-2032
12.4%
Market Size,2032
USD 5,228
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Assisted Reproductive Apparatus was estimated to be worth US$ 2332 million in 2025 and is projected to reach US$ 5228 million, growing at a CAGR of 12.4% from 2026 to 2032.
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Global key players of Assisted Reproductive Apparatus include CooperSurgical, Vitrolife, Cook Medical and Olympus, etc. The top four players hold a share about 50%. China is the largest market, has a share about 50%. In terms of product type, Consumables and Surgical Devices is the largest segment, occupied for a share of about 40%, and in terms of application, Hospitals has a share about 55 percent.
This report provides a comprehensive view of the global market for Assisted Reproductive Apparatus, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Assisted Reproductive Apparatus market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Apparatus.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Assisted Reproductive Apparatus companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Assisted Reproductive Apparatus revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Assisted Reproductive Apparatus revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Assisted Reproductive Apparatus Product Introduction
1.2 Global Assisted Reproductive Apparatus Market Size Forecast (2021–2032)
1.3 Assisted Reproductive Apparatus Market Trends & Drivers
1.3.1 Assisted Reproductive Apparatus Industry Trends
1.3.2 Assisted Reproductive Apparatus Market Drivers & Opportunities
1.3.3 Assisted Reproductive Apparatus Market Challenges
1.3.4 Assisted Reproductive Apparatus Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Assisted Reproductive Apparatus Players Revenue Ranking (2025)
2.2 Global Assisted Reproductive Apparatus Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Assisted Reproductive Apparatus Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Assisted Reproductive Apparatus
2.6 Assisted Reproductive Apparatus Market Competitive Analysis
2.6.1 Assisted Reproductive Apparatus Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Assisted Reproductive Apparatus Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Assisted Reproductive Apparatus revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Assisted Reproductive Apparatus Market Classification
3.1 Introduction by Type
3.1.1 Liquid Products
3.1.2 Consumables and Surgical Devices
3.1.3 Special Instrument
3.1.4 Global Assisted Reproductive Apparatus Sales Value by Type
3.1.4.1 Global Assisted Reproductive Apparatus Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Assisted Reproductive Apparatus Sales Value, by Type (2021–2032)
3.1.4.3 Global Assisted Reproductive Apparatus Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics and Fertility Centers
4.2 Global Assisted Reproductive Apparatus Sales Value by Application
4.2.1 Global Assisted Reproductive Apparatus Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Assisted Reproductive Apparatus Sales Value by Application (2021–2032)
4.2.3 Global Assisted Reproductive Apparatus Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Assisted Reproductive Apparatus Sales Value by Region
5.1.1 Global Assisted Reproductive Apparatus Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Assisted Reproductive Apparatus Sales Value by Region (2021–2026)
5.1.3 Global Assisted Reproductive Apparatus Sales Value by Region (2027–2032)
5.1.4 Global Assisted Reproductive Apparatus Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Assisted Reproductive Apparatus Sales Value, 2021–2032
5.2.2 North America Assisted Reproductive Apparatus Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Assisted Reproductive Apparatus Sales Value, 2021–2032
5.3.2 Europe Assisted Reproductive Apparatus Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Assisted Reproductive Apparatus Sales Value, 2021–2032
5.4.2 Asia Pacific Assisted Reproductive Apparatus Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Assisted Reproductive Apparatus Sales Value, 2021–2032
5.5.2 South America Assisted Reproductive Apparatus Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Assisted Reproductive Apparatus Sales Value, 2021–2032
5.6.2 Middle East & Africa Assisted Reproductive Apparatus Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Assisted Reproductive Apparatus Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Assisted Reproductive Apparatus Sales Value, 2021–2032
6.3 United States
6.3.1 United States Assisted Reproductive Apparatus Sales Value, 2021–2032
6.3.2 United States Assisted Reproductive Apparatus Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Assisted Reproductive Apparatus Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Assisted Reproductive Apparatus Sales Value, 2021–2032
6.4.2 Europe Assisted Reproductive Apparatus Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Assisted Reproductive Apparatus Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Assisted Reproductive Apparatus Sales Value, 2021–2032
6.5.2 China Assisted Reproductive Apparatus Sales Value by Type (%), 2025 vs 2032
6.5.3 China Assisted Reproductive Apparatus Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Assisted Reproductive Apparatus Sales Value, 2021–2032
6.6.2 Japan Assisted Reproductive Apparatus Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Assisted Reproductive Apparatus Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Assisted Reproductive Apparatus Sales Value, 2021–2032
6.7.2 South Korea Assisted Reproductive Apparatus Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Assisted Reproductive Apparatus Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Assisted Reproductive Apparatus Sales Value, 2021–2032
6.8.2 Southeast Asia Assisted Reproductive Apparatus Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Assisted Reproductive Apparatus Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Assisted Reproductive Apparatus Sales Value, 2021–2032
6.9.2 India Assisted Reproductive Apparatus Sales Value by Type (%), 2025 vs 2032
6.9.3 India Assisted Reproductive Apparatus Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 CooperSurgical
7.1.1 CooperSurgical Profile
7.1.2 CooperSurgical Main Business
7.1.3 CooperSurgical Assisted Reproductive Apparatus Products, Services, and Solutions
7.1.4 CooperSurgical Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.1.5 CooperSurgical Recent Developments
7.2 Vitrolife
7.2.1 Vitrolife Profile
7.2.2 Vitrolife Main Business
7.2.3 Vitrolife Assisted Reproductive Apparatus Products, Services, and Solutions
7.2.4 Vitrolife Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.2.5 Vitrolife Recent Developments
7.3 Cook Medical
7.3.1 Cook Medical Profile
7.3.2 Cook Medical Main Business
7.3.3 Cook Medical Assisted Reproductive Apparatus Products, Services, and Solutions
7.3.4 Cook Medical Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.3.5 Cook Medical Recent Developments
7.4 Olympus
7.4.1 Olympus Profile
7.4.2 Olympus Main Business
7.4.3 Olympus Assisted Reproductive Apparatus Products, Services, and Solutions
7.4.4 Olympus Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.4.5 Olympus Recent Developments
7.5 Nikon
7.5.1 Nikon Profile
7.5.2 Nikon Main Business
7.5.3 Nikon Assisted Reproductive Apparatus Products, Services, and Solutions
7.5.4 Nikon Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.5.5 Nikon Recent Developments
7.6 Zeiss
7.6.1 Zeiss Profile
7.6.2 Zeiss Main Business
7.6.3 Zeiss Assisted Reproductive Apparatus Products, Services, and Solutions
7.6.4 Zeiss Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.6.5 Zeiss Recent Developments
7.7 FUJIFILM Irvine Scientific
7.7.1 FUJIFILM Irvine Scientific Profile
7.7.2 FUJIFILM Irvine Scientific Main Business
7.7.3 FUJIFILM Irvine Scientific Assisted Reproductive Apparatus Products, Services, and Solutions
7.7.4 FUJIFILM Irvine Scientific Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.7.5 FUJIFILM Irvine Scientific Recent Developments
7.8 Kitazato
7.8.1 Kitazato Profile
7.8.2 Kitazato Main Business
7.8.3 Kitazato Assisted Reproductive Apparatus Products, Services, and Solutions
7.8.4 Kitazato Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.8.5 Kitazato Recent Developments
7.9 Leica Microsystems
7.9.1 Leica Microsystems Profile
7.9.2 Leica Microsystems Main Business
7.9.3 Leica Microsystems Assisted Reproductive Apparatus Products, Services, and Solutions
7.9.4 Leica Microsystems Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.9.5 Leica Microsystems Recent Developments
7.10 Genea Biomedx
7.10.1 Genea Biomedx Profile
7.10.2 Genea Biomedx Main Business
7.10.3 Genea Biomedx Assisted Reproductive Apparatus Products, Services, and Solutions
7.10.4 Genea Biomedx Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.10.5 Genea Biomedx Recent Developments
7.11 CORNING
7.11.1 CORNING Profile
7.11.2 CORNING Main Business
7.11.3 CORNING Assisted Reproductive Apparatus Products, Services, and Solutions
7.11.4 CORNING Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.11.5 CORNING Recent Developments
7.12 Basecare Medical
7.12.1 Basecare Medical Profile
7.12.2 Basecare Medical Main Business
7.12.3 Basecare Medical Assisted Reproductive Apparatus Products, Services, and Solutions
7.12.4 Basecare Medical Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.12.5 Basecare Medical Recent Developments
7.13 Esco Lifesciences Group
7.13.1 Esco Lifesciences Group Profile
7.13.2 Esco Lifesciences Group Main Business
7.13.3 Esco Lifesciences Group Assisted Reproductive Apparatus Products, Services, and Solutions
7.13.4 Esco Lifesciences Group Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.13.5 Esco Lifesciences Group Recent Developments
7.14 WEGO
7.14.1 WEGO Profile
7.14.2 WEGO Main Business
7.14.3 WEGO Assisted Reproductive Apparatus Products, Services, and Solutions
7.14.4 WEGO Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.14.5 WEGO Recent Developments
7.15 Prodimed S.A.S
7.15.1 Prodimed S.A.S Profile
7.15.2 Prodimed S.A.S Main Business
7.15.3 Prodimed S.A.S Assisted Reproductive Apparatus Products, Services, and Solutions
7.15.4 Prodimed S.A.S Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.15.5 Prodimed S.A.S Recent Developments
7.16 FertiPro
7.16.1 FertiPro Profile
7.16.2 FertiPro Main Business
7.16.3 FertiPro Assisted Reproductive Apparatus Products, Services, and Solutions
7.16.4 FertiPro Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.16.5 FertiPro Recent Developments
7.17 Bred Life Science Technology Inc
7.17.1 Bred Life Science Technology Inc Profile
7.17.2 Bred Life Science Technology Inc Main Business
7.17.3 Bred Life Science Technology Inc Assisted Reproductive Apparatus Products, Services, and Solutions
7.17.4 Bred Life Science Technology Inc Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.17.5 Bred Life Science Technology Inc Recent Developments
7.18 Changhong Technology (Boomingshing Medical and Liyin Precision Medical)
7.18.1 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Profile
7.18.2 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Main Business
7.18.3 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Assisted Reproductive Apparatus Products, Services, and Solutions
7.18.4 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.18.5 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Recent Developments
7.19 Gynetics Medical Products
7.19.1 Gynetics Medical Products Profile
7.19.2 Gynetics Medical Products Main Business
7.19.3 Gynetics Medical Products Assisted Reproductive Apparatus Products, Services, and Solutions
7.19.4 Gynetics Medical Products Assisted Reproductive Apparatus Revenue (US$ Million), 2021–2026
7.19.5 Gynetics Medical Products Recent Developments
8 Industry Chain Analysis
8.1 Assisted Reproductive Apparatus Value Chain
8.2 Assisted Reproductive Apparatus Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Assisted Reproductive Apparatus Sales Model
8.5.2 Sales Channels
8.5.3 Assisted Reproductive Apparatus Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Assisted Reproductive Apparatus market size was US$ 2332 million in 2025 and is forecast to reach a readjusted size of US$ 5228 million by 2032 with a CAGR of 12.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 101
USD 4250.00
(Single User License)
The global Assisted Reproductive Apparatus market was valued at US$ 2332 million in 2025 and is anticipated to reach US$ 5228 million by 2032, at a CAGR of 12.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 138
USD 2900.00
(Single User License)
The global Assisted Reproductive Apparatus market size was US$ 2098 million in 2024 and is forecast to a readjusted size of US$ 4703 million by 2031 with a CAGR of 12.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 104
USD 4250.00
(Single User License)
The global Assisted Reproductive Apparatus market is projected to grow from US$ 2098 million in 2024 to US$ 4703 million by 2031, at a CAGR of 12.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 160
USD 4900.00
(Single User License)
The global market for Assisted Reproductive Apparatus was estimated to be worth US$ 2098 million in 2024 and is forecast to a readjusted size of US$ 4703 million by 2031 with a CAGR of 12.4% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 123
USD 3950.00
(Single User License)
The global market for Assisted Reproductive Apparatus was valued at US$ 2098 million in the year 2024 and is projected to reach a revised size of US$ 4703 million by 2031, growing at a CAGR of 12.4% during the forecast period.
Published Date: 2025-01-19
Pages: 96
USD 2900.00
(Single User License)
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published Date: 2024-04-17
Pages: 175
USD 5600.00
(Single User License)
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published Date: 2024-04-16
Pages: 171
USD 5900.00
(Single User License)
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published Date: 2024-04-07
Pages: 110
USD 4900.00
(Single User License)
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published Date: 2024-01-18
Pages: 123
USD 3950.00
(Single User License)
The global Assisted Reproductive Apparatus market size was US$ 2332 million in 2025 and is forecast to reach a readjusted size of US$ 5228 million by 2032 with a CAGR of 12.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 101
The global Assisted Reproductive Apparatus market was valued at US$ 2332 million in 2025 and is anticipated to reach US$ 5228 million by 2032, at a CAGR of 12.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 138
The global Assisted Reproductive Apparatus market size was US$ 2098 million in 2024 and is forecast to a readjusted size of US$ 4703 million by 2031 with a CAGR of 12.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 104
The global Assisted Reproductive Apparatus market is projected to grow from US$ 2098 million in 2024 to US$ 4703 million by 2031, at a CAGR of 12.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 160
The global market for Assisted Reproductive Apparatus was estimated to be worth US$ 2098 million in 2024 and is forecast to a readjusted size of US$ 4703 million by 2031 with a CAGR of 12.4% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 123
The global market for Assisted Reproductive Apparatus was valued at US$ 2098 million in the year 2024 and is projected to reach a revised size of US$ 4703 million by 2031, growing at a CAGR of 12.4% during the forecast period.
Published: 2025-01-19
Pages: 96
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published: 2024-04-17
Pages: 175
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published: 2024-04-16
Pages: 171
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published: 2024-04-07
Pages: 110
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published: 2024-01-18
Pages: 123
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now